Simultaneous Determination of Verapamil Hydrochloride and Gliclazide in Synthetic Binary Mixture and Combined Tablet Preparation by Chemometric-Assisted Spectroscopy

DOI: 10.4236/jasmi.2012.23026   PDF   HTML     4,176 Downloads   8,520 Views   Citations


In this study, the simultaneous determination of verapamil hydrochloride and gliclazide in pharmaceuticals by chemometric approaches using UV spectrophotometry has been reported. Verapamil hydrochloride (VER) (Benzeneacetonitrile, α-[3-[[2-(3,4-dimethoxyphenyl) ethyl] methylamino]propyl]-3, 4-dimethoxy-α-(1-methylethyl) hydrochloride) is an L-type calcium channel blocker of the phenylalkylamine class. It has been used in the treatment of hypertension, angina pectoris, and cardiac arrhythmia. Gliclazide (GLZ) (1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(4-methylphenyl) sulphonyl]urea) is an oral hypoglycaemic (anti-diabetic) drug and is classified as a second generation sulfonylurea. Spectra of VER and GLZ were recorded at several concentrations within their linear ranges between wavelengths of 200 nm to 400 nm in 0.1N HCl. Partial least squares regression (PLS) and principle components regression (PCR) were used for chemometric analysis of data and the parameters of the chemometric procedures were optimized. The recoveries were satisfactory and statistically comparable. The method was successfully applied to pharmaceutical formulation, tablet, with no interference from excipients as indicated by the recovery study results. The proposed methods are simple, rapid and can be easily used in the quality control of drugs as alternative analysis tools.

Share and Cite:

R. Bhaskar, R. Bhaskar, M. Sagar, V. Saini and K. Bhat, "Simultaneous Determination of Verapamil Hydrochloride and Gliclazide in Synthetic Binary Mixture and Combined Tablet Preparation by Chemometric-Assisted Spectroscopy," Journal of Analytical Sciences, Methods and Instrumentation, Vol. 2 No. 3, 2012, pp. 161-166. doi: 10.4236/jasmi.2012.23026.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] E. Dinte, I. Tomuta, E. M. Mut, R. I. Iovanov and S. Leucuta, “Chemometric Methods for the Simultaneous Assay of Chloramphenicol, Chlorhexidine and Metronidazole during in Vitro Dissolution of Drugs from Mucoadhesive Buccal Gels,” Farmacia, Vol. 58, 2010, pp. 572-582.
[2] N. Benoudjit, F. Melgani and H. Bouzgou, “Multiple Regression Systems for Spectrophotometric Data Analysis,” Chemometrics and Intelligent Laboratory Systems, Vol. 95, No. 2, 2009, pp. 144-149. doi:10.1016/j.chemolab.2008.10.001
[3] R. Sawant, R. Bhangal, R. Joshi and P. Lanke, “Validated Spectrophotometric Methods for Simultaneous Estimation of Paracetamol, Domperidone and Tramadol HCl in Pure and Tablet Dosage Form,” Journal of Chemical Metrology, Vol. 4, 2010, pp. 21-27.
[4] M. S. Araynel, N. Sultana and A. Z. Mirza, “Simultaneous Determination of Gliquidone, Pioglitazone Hydrochloride, and Verapamil in Formulation and Human Serum by RP-HPLC,” Journal of Chromatographic Science, Vol. 49, No. 2, 2011, pp. 114-117. doi:10.1093/chrsci/49.2.114
[5] L. Chytil, B. Strauch, J. Cvacka, V. Maresova and O. Slanar, “Determination of Doxazosin and Verapamil in Human Serum by Fast LC-MS/MS: Application to Document Non-Compliance of Patients,” Journal of Chromatography B, Vol. 878, No. 30, 2010, pp. 3167-3173. doi:10.1016/j.jchromb.2010.09.032
[6] P. N. Dhabale and C. R. Seervi, “Simultaneous UV Spectrophotometric Method for Estimation of Gliclazide and Metformine Hydrochloride in Tablet Dosage Form,” International Journal of Chemical Technology Research, Vol. 2, 2010, pp. 813-817.
[7] G. Rathinavel, U. U. Nath, J. Valarmathy, L. S. Joshua, C. S.Thanuja, M. Ganesh, T. S. Kumar and R. Priyadarsini, “RP-HPLC Method for the Simultaneous Estimation of Rosiglitazone and Gliclazide in Tablets,” E-Journal of Chemistry, Vol. 6, 2009, pp. 1188-1192.
[8] Y. K. Aggarwal, P. J. Gogoi, K. Manna, H. G. Bhatt and V. K. Jain, “A Supercritical Fluid Chromatography/Tandem Mass Spectrometry Method for the Simultaneous Quantification of Metformin and Gliclazide in Human Plasma,” Journal of Pharmaceutical Science, Vol. 72, 2010, pp. 50-57.
[9] G. Venkatesh, V. Ramanathan, S. M. Mansor, N. K. Nair, M. A. Sattar, S. L. Croft and V. Navaratnam, “Development and Validation of RP-HPLC-UV Method or Simultaneous Determination of Buparvaquone, Atenolol, Propranolol, Quinidine and Verapamil: A Tool for the Standardization of Rat in Situ Intestinal Permeability Studies,” Journal of Pharmaceutical Biomedical Analysis, Vol. 43, No. 4, 2007, pp. 1546-1551. doi:10.1016/j.jpba.2006.11.013
[10] Y. Ni, Y. Wang and S. Kokot, “Multicomponent Kinetic Spectrophotometric Determination of Pefloxacin and Norfloxacin in Pharmaceutical Preparations and Human Plasma Samples with the Aid of Chemometrics,” Spectrochimica Acta Part A, Vol. 70, No. 5, 2008, pp. 1049-1059. doi:10.1016/j.saa.2007.10.013
[11] M. J. Culzoni, M. D. Zan, J. C. Robles, V. E. Mantovani and H. C. Goicoechea, “Chemometrics-Assisted UV-Spectroscopic Strategies for the Determination of Theophylline in Syrups,” Journal of Pharmaceutical Biomedical Analysis, Vol. 39, No. 5, 2005, pp. 1068-1074. doi:10.1016/j.jpba.2005.06.009
[12] H. Mark and J. Workman, “Chemometrics in Spectroscopy,” Academic Press, London, 2007.
[13] D. M. Haaland and E. V. Thomas, “Partial Least-Squares Methods for Spectral Analyses,” Analytical Chemiatry, Vol. 60, No. 11, 1988, pp. 1193-1202. doi:10.1021/ac00162a020
[14] P. C. Damiani, A. C. Moschetti, A. J. Rovetto, F. Benavente and A. C. Oliverieri, “Design and Optimization of a Chemometrics-Assisted Spectrophotometric Method for the Simultaneous Determination of Levodopa and Carbidopa in Pharmaceutical Products,” Analytica Chimica Acta, Vol. 543, No. 1-2, 2005, pp. 192-198. doi:10.1016/j.aca.2005.04.065

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.